Skip to main content
Clinical Trials/JPRN-UMIN000048432
JPRN-UMIN000048432RecruitingPhase 4

The effect of active vitamin D on reducing the development of type 2 diabetes from prediabetes (Phase IV, multicenter, randomized, double-blind, placebo controlled, and parallel group comparison) - DPVD plus (Diabetes Prevention with active Vitamin D-for Patients with Low insUlin Secretion) trial (Phase IV, multicenter, randomized, double-blind, placebo controlled, and parallel group comparison)

Shin Komonji Hospital Department of Endocrinology and Diabetes0 sites904 target enrollmentStarted: July 22, 2022Last updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Recruiting
Sponsor
Enrollment
904

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to 90years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Participants are ineligible if they meet any of the following criteria: have a history of diabetes; participate in other clinical trials; have a history of taking anti-diabetes drugs, other active vitamin D, and/or bisphosphonates within the past three months; are pregnant; have coronary, peripheral, or cerebrovascular disease; or have some types of severe diseases (e.g., mental disorder, collagen disease, renal insufficiency, hepatic insufficiency, or terminal disease).

Investigators

Sponsor
Shin Komonji Hospital Department of Endocrinology and Diabetes

Similar Trials